EcoR1 Capital’s Immunomedics Inc IMMU Stock Holding History

EcoR1 Capital’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,860,019	Closed	-$40M	–	51
2017 Q3	$40M	Buy	+2,860,019	New	+$28.5M	5.33%	6

Other funds holding IMMU

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

ACP

Acuta Capital Partners Redwood City, California $143M AUM 773.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

EcoR1 Capital's IMMU Position: Q4 2017 in Review

EcoR1 Capital sold out of Immunomedics Inc (IMMU) in Q4 2017, closing a stake of 2,860,019 shares — an estimated $40M sold.

EcoR1 Capital first reported a position in IMMU in Q3 2017 and held it in 1 quarter. The position peaked at $40M in Q3 2017. 157 funds tracked by Wall St. Rank hold IMMU as of Q4 2017.

EcoR1 Capital reported no remaining Immunomedics Inc position as of Q4 2017 after selling out during the quarter.
EcoR1 Capital sold 2,860,019 Immunomedics Inc shares in Q4 2017, an estimated $40M.
EcoR1 Capital first reported a position in Immunomedics Inc in Q3 2017 and held it in 1 quarter.
EcoR1 Capital's Immunomedics Inc position peaked at $40M in Q3 2017.
157 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2017.

Based on EcoR1 Capital's 13F filing for Q4 2017, filed 14 Feb 2018.